Prevention of liver-related complications with elbasvir/grazoprevir in hepatitis C infected patients who are receiving opioid agonist therapy

被引：0

作者：

Corman, S. ^{[1
]}

Jiang, Y. ^{[2
]}

Platt, H. L. ^{[3
]}

Nwankwo, C. ^{[3
]}

机构：

[1] Pharmerit Int, Bethesda, MD USA

[2] Merck Sharp & Dohme Ltd, Hoddesdon, Herts, England

[3] Merck & Co Inc, Kenilworth, NJ USA

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)30913-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-246

引用

下载

页码：S298 / S298

页数：1

共 50 条

[21] Hepatitis C Treatment as Prevention of Viral Transmission and Liver-Related Morbidity in Persons Who Inject Drugs
Cousien, Anthony
Tran, Viet Chi
Deuffic-Burban, Sylvie
Jauffret-Roustide, Marie
Dhersin, Jean-Stephane
Yazdanpanah, Yazdan
HEPATOLOGY, 2016, 63 (04) : 1090 - 1101
[22] Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice
Norton, Brianna L.
Akiyama, Matthew J.
Zamor, Philippe J.
Litwin, Alain H.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2018, 32 (02) : 347 - +
[23] Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
Chen-Hua Liu
Cheng-Yuan Peng
Yu-Jen Fang
Wei-Yu Kao
Sheng-Shun Yang
Cheng-Kuan Lin
Hsueh-Chou Lai
Wen-Pang Su
Sheng-Uei Fang
Chun-Chao Chang
Tung-Hung Su
Chun-Jen Liu
Pei-Jer Chen
Ding-Shinn Chen
Jia-Horng Kao
Scientific Reports, 10
[24] Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
Liu, Chen-Hua
Peng, Cheng-Yuan
Fang, Yu-Jen
Kao, Wei-Yu
Yang, Sheng-Shun
Lin, Cheng-Kuan
Lai, Hsueh-Chou
Su, Wen-Pang
Fang, Sheng-Uei
Chang, Chun-Chao
Su, Tung-Hung
Liu, Chun-Jen
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
SCIENTIFIC REPORTS, 2020, 10 (01)
[25] Safety and efficacy of elbasvir/grazoprevir in patients infected with hepatitis C virus genotype 4 in Qassim region of Saudi Arabia
Murgod, Shivananda E.
Ahmed, Sumaira
Almutairi, Nawaf
Alqifari, Abdullah
Alharbi, Majed
Shoqueer, Ahmed
INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2023, 17 (02): : 22 - 27
[26] DRUG USE AND REINFECTION DURING AND FOLLOWING HCV TREATMENT WITH ELBASVIR/GRAZOPREVIR AMONG PATIENTS RECEIVING OPIOID AGONIST THERAPY: FINAL RESULTS FROM THE CO-STAR STUDY
Grebely, Jason
Conway, Brian
Litwin, Alain H.
Dalgard, Olav
Shibolet, Oren
Nahass, Ronald G.
Altice, Frederick
Gane, Edward J.
Luetkemeyer, Annie
Peng, Cheng-Yuan
Iser, David
Gendrano, Isaias Noel, III
Kelly, Michelle
Hwang, Peggy
Asante-Appiah, Ernest
Barr, Eliav
Robertson, Michael Newton
Platt, Heather
Dore, Gregory
HEPATOLOGY, 2019, 70 : 955A - 956A
[27] Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
Qurishi, N
Kreuzberg, C
Lüchters, G
Effenberger, W
Kupfer, B
Sauerbruch, T
Rockstroh, JK
Spengler, U
LANCET, 2003, 362 (9397): : 1708 - 1713
[28] Long-term follow-up of chronic hepatitis C patients -: Response to therapy and incidence of liver-related complications.
Pradat, P
Tillmann, HL
Braconier, JH
Saracco, G
Sauleda, S
Thursz, M
Merle, P
Badalamenti, S
Alberti, A
Esteban, JI
Hadziyannis, S
Rizzetto, M
Thomas, H
Manns, M
Trépo, C
HEPATOLOGY, 2003, 38 (04) : 431A - 431A
[29] HCV Reinfection and Injecting Risk Behavior Following Elbasvir/Grazoprevir Treatment in Patients on Opioid Agonist Therapy: Co-STAR Part B
Grebely, Jason
Litwin, Alain Harris
Dalgard, Olav
Gane, Edward J.
Shibolet, Oren
Conway, Brian
Nahass, Ronald
Altice, Frederick
Luetkemeyer, Anne
Peng, Cheng-Yuan
Iser, David
Gendrano, Isaias Noel
Huang, Hsueh-Cheng
Kelly, Michelle M.
Hwang, Peggy
Barr, Eliav
Robertson, Michael Newton
Platt, Heather
Dore, Gregory
HEPATOLOGY, 2018, 68 : 35A - 35A
[30] Late liver-related mortality from complications of transfusion-acquired hepatitis C
Kamitsukasa, H
Harada, H
Tanaka, H
Yagura, M
Tokita, H
Ohbayashi, A
HEPATOLOGY, 2005, 41 (04) : 819 - 825

← 1 2 3 4 5 →